Blog

/Blog
Blog2020-05-05T13:13:48+00:00

Metrion Biosciences and International Scientific Consortium publish data and new recommendations for in vitro risk assessment of the cardiac safety of new medicines

By |May 11th, 2020|Categories: Press Release|Tags: , , , , , , , |

Metrion Biosciences and International Scientific Consortium publish data and new recommendations for in vitro risk assessment of the cardiac safety of new medicines Part of the US [...]

Metrion Biosciences and LifeArc extend ion channel drug discovery collaboration

By |December 3rd, 2019|Categories: Press Release|Tags: , , , , , , |

Metrion Biosciences and LifeArc extend ion channel drug discovery collaboration to accelerate neuroscience-focused research Initial twelve month collaboration successfully identifies hit compounds and progresses into hit-to-lead optimisation phase [...]

Why Metrion’s CSO spent 35 years unlocking the potential of ion channels for drug discovery

By |November 6th, 2019|Categories: Blog|Tags: , , , , , , , , |

Thank you to the ELRIG Committee and to BioStrata for allowing us to share the below content on our website. The British Pharmacological Society (BPS) ran a special [...]

Opportunities for Ion Channel Targeting Antibodies: Current Landscape and Pipeline

By |August 28th, 2019|Categories: Blog|Tags: , , , , , , , |

Metrion Biosciences’ tenth External Speaker Series presentation featured Dr Catherine Hutchings, a highly experienced biologics drug discovery researcher and independent consultant. Dr Hutchings’ presentation included an overview of [...]